TR
EN
Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications
Abstract
The use of luminous glucose sensing as a potential replacement for more traditional forms of glucose measurement has shown encouraging results. Investigation of the efficiency of fluorescence resonance energy transfer (FRET) in glucose sensing is being conducted, with particular focus on the effect of donor-acceptor arrangement. The findings of the experiments indicated that the FRET efficiency was around 50.4% when FITC was used as the acceptor and TRITC was used as the donor. However, the FRET efficiency increased to over 60% when FITC was employed as the donor and TRITC was utilized as the acceptor in the experiment. The significance of the donor-acceptor configuration for efficient energy transfer has been brought to light by the findings presented here. In the process of glucose sensing, the data suggest that FITC should be utilized as the donor, while TRITC should be employed as the acceptor. The engineering medical application of a FITC-TRICTC biosensor requires an excitation wavelength of 544 nm and an absorption wavelength of 516 nm, respectively. In addition to these requirements, you will also need an antenna for transmission that operates at 580 GHz and a wavelength of 551 for the excitation. This article will be an extremely helpful resource for researchers working in the field of fluorescent glucose sensing. The article elucidates the essential concepts of competitive binding and oxidation, both of which are crucial to the process.
Keywords
References
- [1] Fluorescence Excitation and Emission Fundamentals. [accessed 2023 Jan 29].
- [2] Klonoff DC. Fluorescence Glucose Sensing, Part I: Overview of Fluorescence Glucose Sensing: A Technology with a Bright Future. Journal of Diabetes Science and Technology. 2012 [accessed 2023 Jan 29];6(6):1242. /pmc/articles/PMC3570863/. doi:10.1177/193229681200600602
- [3] Carravilla P, Nieva JL, Eggeling C. Fluorescence Microscopy of the HIV-1 Envelope. Viruses. 2020 [accessed 2023 Jan 29];12(3). https://pubmed.ncbi.nlm.nih.gov/32245254/. doi:10.3390/V12030348
- [4] Woo Y, Chaurasiya S, O’Leary M, Han E, Fong Y. Fluorescent imaging for cancer therapy and cancer gene therapy. Molecular Therapy Oncolytics. 2021 [accessed 2023 Jan 29];23:231. /pmc/articles/PMC8531657/. doi:10.1016/J.OMTO.2021.06.007
- [5] Jenkins R, Burdette MK, Foulger SH. Mini-review: fluorescence imaging in cancer cells using dye-doped nanoparticles. RSC Advances. 2016 [accessed 2023 Jan 29];6(70):65459–65474. https://pubs.rsc.org/en/content/articlehtml/2016/ra/c6ra10473h. doi:10.1039/C6RA10473H
- [6] Lwin TM, Turner MA, Amirfakhri S, Nishino H, Hoffman RM, Bouvet M. Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible. Cells 2022, Vol. 11, Page 249. 2022 [accessed 2023 Jan 29];11(2):249. https://www.mdpi.com/2073-4409/11/2/249/htm. doi:10.3390/CELLS11020249
- [7] Chen L, Hwang E, Zhang J. Fluorescent Nanobiosensors for Sensing Glucose. Sensors 2018, Vol. 18, Page 1440. 2018 [accessed 2023 Jan 29];18(5):1440. https://www.mdpi.com/1424-8220/18/5/1440/htm. doi:10.3390/S18051440
- [8] Jernelv IL, Milenko K, Fuglerud SS, Hjelme DR, Ellingsen R, Aksnes A. A review of optical methods for continuous glucose monitoring. Applied Spectroscopy Reviews. 2019 [accessed 2023 Jan 29];54(7):543–572. doi:10.1080/05704928.2018.1486324
Details
Primary Language
English
Subjects
Industrial Biotechnology, Biomedical Engineering
Journal Section
Research Article
Early Pub Date
November 29, 2024
Publication Date
November 30, 2024
Submission Date
March 16, 2023
Acceptance Date
February 21, 2024
Published in Issue
Year 2024 Volume: 7 Number: 2
APA
Naeem, R., & Atilla, D. Ç. (2024). Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications. Kocaeli Journal of Science and Engineering, 7(2), 96-108. https://doi.org/10.34088/kojose.1266492
AMA
1.Naeem R, Atilla DÇ. Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications. KOJOSE. 2024;7(2):96-108. doi:10.34088/kojose.1266492
Chicago
Naeem, Rajaa, and Doğu Çağdaş Atilla. 2024. “Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications”. Kocaeli Journal of Science and Engineering 7 (2): 96-108. https://doi.org/10.34088/kojose.1266492.
EndNote
Naeem R, Atilla DÇ (November 1, 2024) Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications. Kocaeli Journal of Science and Engineering 7 2 96–108.
IEEE
[1]R. Naeem and D. Ç. Atilla, “Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications”, KOJOSE, vol. 7, no. 2, pp. 96–108, Nov. 2024, doi: 10.34088/kojose.1266492.
ISNAD
Naeem, Rajaa - Atilla, Doğu Çağdaş. “Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications”. Kocaeli Journal of Science and Engineering 7/2 (November 1, 2024): 96-108. https://doi.org/10.34088/kojose.1266492.
JAMA
1.Naeem R, Atilla DÇ. Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications. KOJOSE. 2024;7:96–108.
MLA
Naeem, Rajaa, and Doğu Çağdaş Atilla. “Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications”. Kocaeli Journal of Science and Engineering, vol. 7, no. 2, Nov. 2024, pp. 96-108, doi:10.34088/kojose.1266492.
Vancouver
1.Rajaa Naeem, Doğu Çağdaş Atilla. Fluorescence Glucose Biosensors Assays Analysis and Novel Classifications: Frequency Range Specification for Medical Applications. KOJOSE. 2024 Nov. 1;7(2):96-108. doi:10.34088/kojose.1266492